Intralesional Immunotherapy of Warts With Mumps, Candida, and Trichophyton Skin Test Antigens
Author(s) -
Thomas Horn,
Sandra Marchese Johnson,
Ricki M. Helm,
Paula K. Roberson
Publication year - 2005
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.141.5.589
Subject(s) - medicine , antigen , immunotherapy , immunology , peripheral blood mononuclear cell , mumps virus , trichophyton rubrum , interferon alfa , immune system , dermatology , virus , in vitro , biology , biochemistry , antifungal
Warts occur commonly in humans. Destructive modalities are generally the first physician-administered therapy. Other treatment options include immunotherapy. Intralesional immunotherapy using mumps, Candida, or Trichophyton skin test antigens has proved efficacy in the treatment of warts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom